Skip to content
2000
Volume 18, Issue 7
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Anomalous protein-protein interactions (PPIs) have been correlated to a variety of disease states, such as cancer, infectious disease, neurological disorders, diabetes, endocrine disorders and cardiovascular disease. Stapled peptides are an emerging intervention for these PPIs due to their improved structural rigidity and pharmacokinetic properties relative to unstapled peptides. This review details the most recent advances in the field of stapled peptide therapeutics, including the increasing variety of PPIs being targeted and types of peptide staples being employed.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026618666180518095255
2018-03-01
2025-09-17
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026618666180518095255
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test